Adverum Stock Performance

ADVM
 Stock
  

USD 0.66  0.02  2.94%   

The firm shows a Beta (market volatility) of 1.0211, which signifies a somewhat significant risk relative to the market. Let's try to break down what Adverum's beta means in this case. Adverum Biotechnologies returns are very sensitive to returns on the market. As the market goes up or down, Adverum Biotechnologies is expected to follow. Even though it is essential to pay attention to Adverum Biotechnologies historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Adverum Biotechnologies exposes twenty-one different technical indicators, which can help you to evaluate its performance. Adverum Biotechnologies has an expected return of -0.73%. Please be advised to confirm Adverum Biotechnologies variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Adverum Biotechnologies performance from the past will be repeated at some point in the near future.
  
Adverum Performance
0 of 100
Over the last 90 days Adverum Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively steady which may send shares a bit higher in January 2023. The new chaos may also be a sign of medium-term up-swing for the company stakeholders. ...more

Adverum Price Channel

Begin Period Cash Flow63423000.00
Total Cashflows From Investing Activities78709000.00

Adverum Biotechnologies Relative Risk vs. Return Landscape

If you would invest  110.00  in Adverum Biotechnologies on September 7, 2022 and sell it today you would lose (44.00)  from holding Adverum Biotechnologies or give up 40.0% of portfolio value over 90 days. Adverum Biotechnologies is currently does not generate positive expected returns and assumes 4.022% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Adverum, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Adverum Biotechnologies is expected to under-perform the market. In addition to that, the company is 2.65 times more volatile than its market benchmark. It trades about -0.18 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.05 per unit of volatility.

Adverum Biotechnologies Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Adverum Biotechnologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Adverum Biotechnologies, and traders can use it to determine the average amount a Adverum Biotechnologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1811

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsADVM
Estimated Market Risk
 4.02
  actual daily
 
 34 %
of total potential
 
3434
Expected Return
 -0.73
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.18
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Adverum Biotechnologies is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adverum Biotechnologies by adding it to a well-diversified portfolio.

About Adverum Biotechnologies Performance

To evaluate Adverum Biotechnologies Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Adverum Biotechnologies generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Adverum Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Adverum Biotechnologies market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Adverum's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-696.6 K-714.9 K
Return on Investment(44.78) (48.32) 
Return on Average Assets(31.56) (34.05) 
Return on Average Equity(38.78) (41.84) 
Return on Invested Capital(0.29) (0.29) 
Return on Sales(17.46) (18.84) 

Things to note about Adverum Biotechnologies

Checking the ongoing alerts about Adverum Biotechnologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adverum Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Adverum Biotechnologies Alerts

Equity Alerts and Improvement Suggestions

Adverum Biotechnologies generated a negative expected return over the last 90 days
Adverum Biotechnologies has some characteristics of a very speculative penny stock
Adverum Biotechnologies has high historical volatility and very poor performance
The company reported the previous year's revenue of 7.5 M. Net Loss for the year was (145.54 M) with loss before overhead, payroll, taxes, and interest of (81.68 M).
Adverum Biotechnologies currently holds about 235.84 M in cash with (107.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Adverum Biotechnologies has a frail financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Please continue to Trending Equities. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for analysis

When running Adverum Biotechnologies price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
66.4 M
Quarterly Revenue Growth YOY
(0.70) 
Return On Assets
(0.23) 
Return On Equity
(0.56) 
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Adverum Biotechnologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.